On-demand biomanufacturing through synthetic biology approach

Biopharmaceuticals including protein therapeutics, engineered protein-based vaccines and monoclonal antibodies, are currently the mainstay products of the biotechnology industry. However, the need for specialized equipment and refrigeration during production and distribution poses challenges for the...

Full description

Saved in:
Bibliographic Details
Published inMaterials today bio Vol. 18; p. 100518
Main Authors Tang, Chenwang, Wang, Lin, Zang, Lei, Wang, Qing, Qi, Dianpeng, Dai, Zhuojun
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Biopharmaceuticals including protein therapeutics, engineered protein-based vaccines and monoclonal antibodies, are currently the mainstay products of the biotechnology industry. However, the need for specialized equipment and refrigeration during production and distribution poses challenges for the delivery of these technologies to the field and low-resource area. With the development of synthetic biology, multiple studies rewire the cell-free system or living cells to impact the portable, on-site and on-demand manufacturing of biomolecules. Here, we review these efforts and suggest future directions. On demand biomanufacturing. In this review, we summarize approaches that consisting of cell-free protein synthesis (CFPS) and living cellular hosts to achieve the on demand biomanufacturing of vaccines, antibodies, enzymes, proteins or small molecules drugs. [Display omitted]
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contribute equally.
ISSN:2590-0064
2590-0064
DOI:10.1016/j.mtbio.2022.100518